<DOC>
	<DOC>NCT00745355</DOC>
	<brief_summary>The purpose of this study is to learn about the quality of life of people living with bladder cancer. We are interested in learning about how the treatments for bladder cancer affect people. We plan to use the findings from this study to help doctors provide better care and information to patients with bladder cancer.</brief_summary>
	<brief_title>Quality of Life in Patients With Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>All patients (male and female) who are diagnosed with bladder cancer Patients must be scheduled for radical cystectomy and urinary diversion are and/or being evaluated for neoadjuvant chemotherapy prior to a planned cystectomy. Participants must be able to speak English. Participants must be able to provide informed consent. Participants must be 18 years of age or older to enroll. Participant may be eligible for and may receive neoadjuvant or adjuvant chemotherapy. Participant may have had intravesicle chemotherapy or immunotherapy (BCG, Interferon). Subjects may be excluded from the study based on the following criteria: Followup care not obtained at MSKCC. Metastatic disease at diagnosis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Quality of Life</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>08-076</keyword>
</DOC>